Open AccessAnti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Author(s) -
Gerard J. Criner,
Frederick Lang,
Robert L Gottlieb,
Kusum S. Mathews,
Tisha S. Wang,
Todd W. Rice,
Deepu Madduri,
Shashi Bellam,
Robert Jeanfreau,
Amy Hajari Case,
Marilyn K. Glassberg,
G. Marshall Lyon,
Kareem Ahmad,
Robert Mendelson,
J. Michael DiMaio,
MaryAnn P Tran,
Cedric W. Spak,
Jamil A Abbasi,
Steven G Davis,
Shekhar Ghamande,
Steven S. Shen,
Lisa Sherman,
Simon Lowry
Publication year - 2022
Publication title -
american journal of respiratory and critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.272
H-Index - 374
eISSN - 1535-4970
pISSN - 1073-449X
DOI - 10.1164/rccm.202108-1859oc
Subject(s) - medicine , pneumonia , monoclonal antibody , covid-19 , immunology , randomized controlled trial , granulocyte macrophage colony stimulating factor , placebo , granulocyte , monoclonal , antibody , virology , cytokine , pathology , outbreak , alternative medicine , disease , infectious disease (medical specialty)